Overproduced reactive oxygen species and the induced oxidative stress and neuroinflammation often result in secondary injury, which is associated with unfavorable prognosis in traumatic brain injury (TBI). Unfortunately, current medications cannot effectively ameliorate the secondary injury at traumatic sites. Here, it is reported that intrinsically bioactive multifunctional nanocomposites (ANGâMnEMNPsâCur, AMEC) mediate antioxidation and antiâneuroinflammation for targeted TBI theranostics, which are engineered by loading the neuroprotective agent curcumin on angiopepâ2 functionalized and manganese doped eumelaninâlike nanoparticles. After intravenous delivery, efficient AMEC accumulation is observed in lesions of TBI mice models established by controlled cortical impact method, evidenced by T1âT2 magnetic resonance and photoacoustic dualâmodal imaging. Therapeutically, AMEC effectively alleviates neuroinflammation, protects bloodâbrain barrier integrity, relieves brain edema, reduces brain tissue loss, and improves the cognition of TBI mice. Mechanistically, following the penetration into the traumatic tissues via angiopepâ2 mediated targeting effect, the efficacy of AMEC is synergistically improved by combined functional moieties of curcumin and eumelanin. This is achieved by the alleviation of oxidative stress, inhibition of neuroinflammation via M1âtoâM2 macrophage reprogramming, and promotion of neuronal regeneration. The asâdeveloped AMEC with wellâdefined mechanisms of action may represent a promising targeted theranostics strategy for TBI and other neuroinflammationâassociated intracranial diseases.